The final, formatted version of the article will be published soon.
ORIGINAL RESEARCH article
Front. Pharmacol.
Sec. Ethnopharmacology
Volume 15 - 2024 |
doi: 10.3389/fphar.2024.1301002
This article is part of the Research Topic Global Excellence in Ethnopharmacology: Africa View all 9 articles
Mimosa pudica L. aqueous extract protects mice against pilocarpine-picrotoxin kindling-induced temporal lobe epilepsy, oxidative stress, alteration in GABAergic/cholinergic pathways and BDNF expression
Provisionally accepted- University of Buea, Buea, Cameroon
Ethnopharmacological studies revealed that the leaves and stems of Mimosa pudica L. (Fabaceae) are widely used for the treatment of epilepsy. This study sought to investigate the effects of the aqueous extract of Mimosa pudica leaves and stems against pilocarpine-picrotoxin kindlinginduced temporal lobe epilepsy in mice, and its implication on oxidative/nitrosative stress, GABAergic/cholinergic signalling and brain derived neurotrophic factors (BDNF) expression.Animals were treated for seven consecutive days as follows: one normal group and one negative control group that received orally distilled water; four test groups that received orally four doses of Mimosa pudica (20, 40, 80, and 160 mg/kg), respectively; and one positive control group that received intraperitoneally 300 mg/kg sodium valproate. One hour after the first treatment (first day), status epilepticus was induced by intraperitoneal injection of a single dose of pilocarpine (360 mg/kg). Twenty-three hours after the injection of pilocarpine to mice, they received once again their different treatments. Sixty minutes later, they were injected with a sub-convulsive dose of picrotoxin (1 mg/kg), and the anticonvulsant property of the extract was determined. On dayseven, open field, rotarod and catalepsy tests were performed. Finally, mice were sacrificed and the hippocampus were isolated to quantify some biochemical markers of oxidative/nitrosative stress, GABAergic/cholinergic signaling and BDNF levels in the hippocampus. Mimosa pudica extracts (160 mg/kg) significantly increased the latency time to status epilepticus by 70.91%. Its significantly decreased the number of clonic and tonic seizures to 9.33±1.03 and 5.00±0.89, and their duration to 11.50±2.07 and 6.83±0.75 s, respectively. Exploratory behaviour, motor coordination and catalepsy were significantly ameliorated, respectively in the open field, rotarod and catalepsy tests. Pilocarpine-picrotoxin-induced alteration of oxidant-antioxidant balance, GABA-transaminase stability, acetylcholinesterase/butyrilcholinesterase activity, and neurogenesis were attenuated by the extract (80-160 mg/kg). This study showed that the aqueous extract of Mimosa pudica leaves and stems ameliorated epileptogenesis of temporal lobe epilepsy and could be used for the treatment of temporal lobe epilepsy.
Keywords: Mimosa pudica, Temporal Lobe Epilepsy, Oxidative Stress, GABAergic status, Cholinergic status, Brain derived neurotrophic factors
Received: 23 Sep 2023; Accepted: 19 Dec 2024.
Copyright: © 2024 Mambou, Bopda, SIMON, Tita Jugha, Nji, Ojongnkpot, Wanyu, Bess Bila and Taiwe. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Germain Sotoing Taiwe, University of Buea, Buea, Cameroon
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.